Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication

BACKGROUND: All Helicobacter pylori-infected patients are recommended for eradication with an appropriate regimen in each geographic area. The choice of the therapy is somewhat dependent on the antimicrobial susceptibility. The rate of clarithromycin resistance has been increasing and is associated...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Clin Microbiol Antimicrob
Main Authors: Tanabe, Hiroki, Yoshino, Keiichi, Ando, Katsuyoshi, Nomura, Yoshiki, Ohta, Katsuhisa, Satoh, Kiichi, Ichiishi, Eiichiro, Ishizuka, Akiei, Otake, Takaaki, Kohgo, Yutaka, Fujiya, Mikihiro, Okumura, Toshikatsu
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6022507/
https://ncbi.nlm.nih.gov/pubmed/29950163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12941-018-0281-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados